Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral Drug Adverse Reaction”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT06180590
What this trial is testing

The Efficacy of Vosevi in Treating DAA-experienced Patients

Who this might be right for
Chronic Hepatitis CMedication Reaction
The Third Affiliated Hospital of Guangzhou Medical University 200
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Not applicableStudy completedNCT03602703
What this trial is testing

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

Who this might be right for
Drug-Induced Liver Injury
Assiut University 42
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Post-approval studies (Phase 4)UnknownNCT03296930
What this trial is testing

Effect Of DAAs For Treatment Of HCV On Normal Kidney

Who this might be right for
Antiviral Drug Adverse Reaction
Assiut University 100
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT03251144
What this trial is testing

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

Who this might be right for
HIV/AIDSAntiviral ToxicityAntiviral Drug Adverse Reaction+1 more
University of California, Los Angeles 26
Not applicableUnknownNCT03775798
What this trial is testing

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Who this might be right for
Hepatitis CCirrhosisAntiviral Drug Adverse Reaction
Austral University, Argentina 2,200
Not applicableStudy completedNCT03423641
What this trial is testing

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 33,808
Not applicableUnknownNCT03566030
What this trial is testing

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

Who this might be right for
Hepatitis BAntiviral Drug Adverse Reaction
Yonsei University 300